Organization
The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
3 abstracts
Abstract
Detecting early stage breast cancer using low-depth cell-free DNA fragmentomics: A multi-center cohort study.Org: Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China, Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China,
Abstract
Preliminary results from a first-in-human study of ESG401, a trophoblast cell-surface antigen 2 (TROP2) antibody drug conjugate (ADC), in patients with locally advanced/metastatic solid tumors.Org: National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China, Department of Medical Oncology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China, Tianjin cancer hospital ,China, Tianjin, China, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China,
Abstract
Prophylactic hyperthermic intraperitoneal chemotherapy in T4 colorectal cancer: Can it improve the oncologic prognosis?Org: The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, zhejiang, China,